Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression

Published:2017-11 Issue: Volume:408 Page:155-163
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Chen Jiaqi,Li Lei,Yang Zhao,Luo Jie,Yeh Shuyuan,Chang Chawnshang

Funder

NIH

Taiwan Department of Health Clinical Trial and Research Center of Excellence

National Natural Science Foundation of China

National Key Research and Development Program

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference61 articles.

1. NCCN guidelines insights: prostate cancer early detection, version 2.2016;Carroll;J. Natl. Compr. Cancer Netw.,2016

2. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

3. Recent advances in bone-targeted therapies of metastatic prostate cancer;Deng;Cancer Treat. Rev.,2014

4. Androgen receptor in prostate cancer;Heinlein;Endocr. Rev.,2004

5. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J. Clin.,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eph receptors and ephrins in cancer progression;Nature Reviews Cancer;2023-11-23

2. RNA-Sequencing Analysis Indicates That N-Cadherin Promotes Prostate Cancer Progression by the Epigenetic Modification of Key Genes;DNA and Cell Biology;2023-09-01

3. Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer;Frontiers in Oncology;2023-08-09

4. MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer;BMC Cancer;2022-11-11

5. Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer;Cells;2022-03-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3